BioVie Inc

BioVie Inc(BIVI)財務資料

$1.340

+0.144 (+10.74%)收盤時

BIVI 獲利能力與利潤率

Evaluating the bottom line, BioVie Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -151.06%, provide a clear picture of how effectively BIVI converts its operational activities into shareholder value.

BIVI 同業比較

In the context of the broader market, BIVI competes directly with industry leaders such as TCRX and GUTS. With a market capitalization of $11.63M, it holds a significant position in the sector. When comparing efficiency, BIVI's gross margin of N/A stands against TCRX's 100.00% and GUTS's N/A. Such benchmarking helps identify whether BioVie Inc is trading at a premium or discount relative to its financial performance.

BioVie Inc 財務表現

BioVie has reported negative net income consistently, with the latest quarterly loss at $5,270,299. The current ratio has dropped to 3.59, indicating a decrease in liquidity. The forward P/E ratio is 0, showing no expected earnings growth in the near term.

Financials

FY2026Q4
0.00
Total Revenue
FY2026Q4
YoY:
+77.17%
-6.11M
Operating Profit
FY2026Q4
YoY:
+61.80%
-5.65M
Net Income after Tax
FY2026Q4
YoY:
-62.23%
-0.71
EPS - Diluted
FY2026Q4
YoY:
-26.50%
-4.12M
Free Cash Flow

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易